Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coya Therapeutics (COYA) Profit After Tax (2022 - 2025)

Coya Therapeutics (COYA) has disclosed Profit After Tax for 4 consecutive years, with -$5.7 million as the latest value for Q4 2025.

  • Quarterly Profit After Tax fell 95.78% to -$5.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$21.2 million through Dec 2025, down 42.64% year-over-year, with the annual reading at -$21.2 million for FY2025, 42.64% down from the prior year.
  • Profit After Tax hit -$5.7 million in Q4 2025 for Coya Therapeutics, down from -$2.1 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $1.3 million in Q4 2023 to a low of -$7.3 million in Q1 2025.
  • Historically, Profit After Tax has averaged -$3.5 million across 4 years, with a median of -$3.3 million in 2022.
  • Biggest five-year swings in Profit After Tax: skyrocketed 140.74% in 2023 and later crashed 330.32% in 2024.
  • Year by year, Profit After Tax stood at -$3.1 million in 2022, then skyrocketed by 140.74% to $1.3 million in 2023, then plummeted by 330.32% to -$2.9 million in 2024, then crashed by 95.78% to -$5.7 million in 2025.
  • Business Quant data shows Profit After Tax for COYA at -$5.7 million in Q4 2025, -$2.1 million in Q3 2025, and -$6.1 million in Q2 2025.